Plasma Fractionation Market Size Worth $45.11 Billion By 2030 | CAGR: 6.8%

Plasma Fractionation Market Size Worth $45.11 Billion By 2030 | CAGR: 6.8%

The global plasma fractionation market size is expected to reach USD 45.11 billion by 2030, according to a new study by Polaris Market Research. The report “Plasma Fractionation Market Share, Size, Trends, Industry Analysis Report, By Product (Albumin, Immunoglobulins); By Method (Centrifugation, Depth Filtration); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.


Plasma fractionation is a method of separating plasma derivatives. There are many blood collection facilities around the world, and new advancements in technology are increasing the collection of blood. Increasing government initiatives and funding for biotechnology and pharmaceutical R&D are expected to boost industry growth.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:


As the R&D in the pharmaceutical & biotechnology sectors is growing concerning plasma treatments, the market is anticipated to grow. The outbreak of the Covid-19 pandemic had negatively impacted the market. Worldwide lockdown and stringent regulation had affected the health systems worldwide, including blood donation and supply as well as clinical transfusion management.


Plasma Fractionation Market Report Highlights

  • Oncology segment is expected to grow at a higher rate during the forecast period with the increasing prevalence of cancer and the use of therapy in treatment
  • The centrifugation segment accounted for the highest revenue share in 2021 and is expected to continue its dominance owing to the high-quality blood supernatant that we get through the centrifugation process.
  • Hospitals & clinics segment is expected to continue its dominance during the forecast period. With improved infrastructure and technologically advanced healthcare services, the demand is rising.
  • Asia Pacific is expected to grow at a significant rate during the forecast period owing to the increasing geriatric population as well as rising investment in R&D.
  • Major players operating in the industry include Grifols, S.A., Shire, Octapharma AG, Kedrion S.P.A, LFB, Biotest AG, Sanquin, China Biologic Products Holdings Inc., GC Pharma, Bio Products Ltd., Japan Blood Products Organization, Emergent BioSolutions, Shanghai Raas Blood Products Co., Ltd., Intas Pharmaceuticals Ltd., Bharat Serum Vaccines Limited


Polaris Market Research has segmented the Plasma Fractionation market report based on product, application, method, end-use, and region:


Plasma Fractionation, Product Outlook (Revenue - USD Billion, 2018 - 2030)

  • Albumin
  • Immunoglobulins
  • Coagulation Factors
  • Protease Inhibitors
  • Others


Plasma Fractionation, Application Outlook (Revenue - USD Billion, 2018 - 2030)

  • Neurology
  • Hematology
  • Oncology
  • Immunology
  • Pulmonology
  • Others


Plasma Fractionation, Method Outlook (Revenue - USD Billion, 2018 - 2030)

  • Centrifugation
  • Depth Filtration
  • Chromatography
  • Others


Plasma Fractionation, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

  • Hospitals & Clinics
  • Clinical Research
  • Others


Plasma Fractionation, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa